CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Sabag Mark acquired 52,113 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Planned sale Hughes Eric A sold 11,277 shares at $32.46 ($366,102)
- 4 Exercise or conversion EVP, Chief Financial Officer acquired 56,763 shares (option exercise)
- 4 Planned sale EVP, U.S. Commercial sold 9,098 shares at $32.46 ($295,362)
- 4 Open-market sale Interim Chief Legal Officer sold 2,675 shares at $32.46 ($86,843)
- 4 Exercise or conversion Chief Accounting Officer acquired 16,329 shares (option exercise)
- 4 Exercise or conversion Chief Accounting Officer acquired 5,179 shares (option exercise)
- 4 Planned sale EVP, Europe Commercial sold 128,985 shares at $32.36 ($4,173,942)
- 4 Exercise or conversion Sabag Mark acquired 166,378 shares (option exercise)
- 4 Open-market sale Interim Chief Legal Officer sold 1,274 shares at $32.36 ($41,227)
- 4 Planned sale President and CEO sold 442,935 shares at $32.36 ($14,333,332)
- 4 Exercise or conversion EVP, Chief Financial Officer acquired 191,278 shares (option exercise)
- 4 Planned sale Hughes Eric A sold 80,762 shares at $32.36 ($2,613,450)
- 4 Planned sale EVP, Chief Financial Officer sold 345,810 shares at $33.64 ($11,634,708)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President and CEO sold 447,778 shares at $34.22 ($15,324,799)
- 4 Derivatives Options or other derivatives
Page 4 of 34 · 666 filings